Impairment of the TSH signal transduction system in human thyroid carcinoma cells

H Kimura1, S Yamashita, H Namba

  • 1First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

Insights

Thyroid-stimulating hormone (TSH) receptor in thyroid cancer cells shows unresponsiveness. This suggests a TSH receptor-G protein coupling abnormality, not reduced receptor expression, impacts cancer cell function.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyroid-stimulating hormone (TSH) plays a crucial role in normal thyroid function.
  • Understanding TSH signaling in thyroid carcinoma is vital for targeted therapies.
  • Previous studies suggest TSH may influence thyroid cancer cell behavior.

Purpose of the Study:

  • To investigate the functional role of the TSH receptor in human thyroid carcinoma cell lines.
  • To compare TSH signal transduction in cancer cells versus normal thyroid cells.
  • To identify potential defects in TSH receptor signaling in thyroid cancer.

Main Methods:

  • Analysis of TSH receptor function in NPA and WRO thyroid carcinoma cell lines.
  • Measurement of cyclic adenosine monophosphate (cAMP) production and [3H]thymidine incorporation.
  • Assessment of TSH receptor mRNA and thyroglobulin mRNA expression.
  • Stimulation assays using forskolin, cholera toxin, and isoproterenol.

Main Results:

  • NPA and WRO cells demonstrated unresponsiveness to both bovine and human TSH.
  • cAMP production was inducible by forskolin, cholera toxin, and isoproterenol, indicating functional downstream pathways.
  • Specific binding of 125I-TSH was observed, along with TSH receptor and thyroglobulin mRNA.
  • TSH did not regulate thyroid-specific gene expression in these carcinoma cells.

Conclusions:

  • Thyroid carcinoma cells exhibit TSH unresponsiveness, likely due to impaired TSH receptor-G protein coupling.
  • This defect appears independent of TSH receptor expression levels or Gs protein abnormalities.
  • Findings highlight a specific molecular mechanism contributing to altered TSH signaling in thyroid cancer.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...